Comments
Caplin Steriles, a wholly-owned subsidiary of Caplin Point Laboratories , has received the Establishment Inspection Report from the US Food and Drug Administration for the recently concluded inspection in June. This was the third successful US FDA audit of the plant since 2016, the company said in a statement to the exchanges. Shares of Caplin Point jumped 10.30 per cent at ₹425.80 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.